Zobrazeno 1 - 2
of 2
pro vyhledávání: '"J Lansens"'
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Background: Rare cancers occur with an incidence of no more than six cases per 100,000 people according to the definition used by the Surveillance of Rare Cancers in Europe project. For a variety of reasons (low prevalence, cytotoxicity), it is chall
Externí odkaz:
https://doaj.org/article/508585f669154a609227c9330429a7d9
Autor:
Dooms M; Department of Pharmaceutical and Pharmacological Sciences, Faculty of Pharmaceutical Sciences, Clinical Pharmacology and Pharmacotherapy Research Group, KU Leuven, Leuven, Belgium., Saesen R; Department of Pharmaceutical and Pharmacological Sciences, Faculty of Pharmaceutical Sciences, Clinical Pharmacology and Pharmacotherapy Research Group, KU Leuven, Leuven, Belgium., Steemans I; Department of Pharmaceutical and Pharmacological Sciences, Faculty of Pharmaceutical Sciences, Clinical Pharmacology and Pharmacotherapy Research Group, KU Leuven, Leuven, Belgium., Lansens J; Department of Pharmaceutical and Pharmacological Sciences, Faculty of Pharmaceutical Sciences, Clinical Pharmacology and Pharmacotherapy Research Group, KU Leuven, Leuven, Belgium., Huys I; Department of Pharmaceutical and Pharmacological Sciences, Faculty of Pharmaceutical Sciences, Clinical Pharmacology and Pharmacotherapy Research Group, KU Leuven, Leuven, Belgium.
Publikováno v:
Frontiers in pharmacology [Front Pharmacol] 2022 May 02; Vol. 13, pp. 775217. Date of Electronic Publication: 2022 May 02 (Print Publication: 2022).